Nicolas Roche

42PUBLICATIONS

436CO-AUTHORS

Major global burdens of diseasePowder and particle technologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Panel data analysis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (42)

Sort by Publication Date:

|Jun 24, 2026

Global disparities in chronic dyspnoea prevalence in population-based studies: a comprehensive literature review.

|May 11, 2026

Clinical impact and healthcare resource utilisation in patients with unexplained or refractory chronic cough: a French national population study.

|Mar 09, 2026

Response to the Letter to the Editor by Zambelli et al for In Silico Lung Deposition Profiles of Three Single-Inhaler Triple Therapies in Patients With COPD Using Functional Respiratory Imaging [Response To Letter].

Dave Singh, Nicolas Roche, Libo Wu

|Jan 22, 2026

Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric study.

Charlène Lefèvre, Théo Funck-Brentano, Marine Cachanado

|Dec 17, 2025

Characteristics and real-world health clinical outcomes of uncontrolled COPD patients: population-based study in France.

Nicolas Roche, Nicolas Molinari, Laurence Watier

|Sep 30, 2025

Economic Burden of Uncontrolled COPD Under Triple Therapy: A Population-Based Study.

Nicolas Molinari, Nicolas Roche, Anne-Lise Vataire

Pageof 7

Frequent Collaborators

David Price

Alberto Papi

David M G Halpin

Bartolome R Celli

Pierre-Régis Burgel

Jean Bourbeau

Désirée Larenas-Linnemann

3 joint publications

Huib A M Kerstjens

3 joint publications

Leonardo M Fabbri

3 joint publications

Nikolaos G Papadopoulos

Frequent Collaborators

David Price

Alberto Papi

David M G Halpin

Bartolome R Celli